Halozyme Therapeutics (HALO) Interest Coverage Ratio (2013 - 2026)
Halozyme Therapeutics' (HALO) Interest Coverage Ratio came in at 51.48 for Q2 2026, up 11.7% from 46.07 a year earlier and up 53.7% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest Coverage Ratio at Halozyme Therapeutics was 29.41, down 22.5% year-over-year; for FY2025, it was 25.87, down 15.1% from FY2024.
- In prior years, Halozyme Therapeutics' Interest Coverage Ratio was 30.48 in FY2024 (+69.4%), 17.99 in FY2023 (+14.0%), 15.79 in FY2022 (-56.9%) and 36.66 in FY2021 (+417.9%).
- The Q2 2026 figure stands as the highest quarterly Interest Coverage Ratio since Q2 2021.
- The strongest year-over-year quarter for Interest Coverage Ratio in the past five years was Q3 2021, with growth of 433.6%; the weakest was Q2 2022, with a decline of 79.3%.
- According to Business Quant data, Interest Coverage Ratio for the three prior quarters was 33.50 (Q1 2026), -18.91 (Q4 2025) and 50.73 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 51.48 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.48 |
| Mar 31, 2026 | 33.50 |
| Dec 31, 2025 | -18.91 |
| Sep 30, 2025 | 50.73 |
| Jun 30, 2025 | 46.07 |
| Mar 31, 2025 | 31.28 |
| Dec 31, 2024 | 38.66 |
| Sep 30, 2024 | 36.07 |
| Jun 30, 2024 | 25.91 |
| Mar 31, 2024 | 21.20 |
| Dec 31, 2023 | 19.36 |
| Sep 30, 2023 | 19.60 |
| Jun 30, 2023 | 21.02 |
| Mar 31, 2023 | 11.84 |
| Dec 31, 2022 | 16.30 |
| Sep 30, 2022 | 11.08 |
| Jun 30, 2022 | 10.97 |
| Mar 31, 2022 | 43.02 |
| Dec 31, 2021 | 27.51 |
| Sep 30, 2021 | 43.09 |
API Access
Halozyme Therapeutics Interest Coverage Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-coverage-ratio", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();